FDA Approval for Axi-Cel in NHL – OncLive
OncLive |
FDA Approval for Axi-Cel in NHL
OncLive David Maloney, MD, PhD: We're tremendously excited to have an approved CAR T-cell for lymphoma. And axi-cel, or axicabtagene ciloleucel, was the first one. The results for the study were basically treating 101 patients with a CAR and they had to have … |
